β¨ Medicines and Tax Notices
NEW ZEALAND GAZETTE
No. 36
Product:
Recormon
Active Ingredient:
Epoetin beta 10,000IU
Dosage Form:
Solution for injection (0.6mL pre-filled syringe)
Active Ingredient:
Epoetin beta 5,000IU
Dosage Form:
Solution for injection (0.3mL pre-filled syringe)
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 500IU
Dosage Form:
Solution for injection (0.3mL pre-filled syringe)
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 6,000IU
Dosage Form:
Solution for injection (0.3mL pre-filled syringe)
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Dated this 3rd day of April 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2337
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Product:
Free & Lovely Dry/Sensitive Scalp
Active Ingredient:
Pyrithione zinc 0.5%w/w
Dosage Form:
Shampoo
New Zealand Sponsor:
Wella New Zealand Limited
Manufacturer:
Cosmetic Products Pty Limited, Somersby, New South Wales, Australia
Dated this 3rd day of April 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2336
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Rescriptor
Active Ingredient:
Delavirdine mesylate 100mg equivalent to 82.6mg delavirdine base
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer Laboratories Limited
Manufacturer:
Pharmacia & Upjohn Caribe Inc, Arecibo, Puerto Rico
Note: This consent is valid for two years from 1 March 2003.
Dated this 3rd day of April 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2338
Inland Revenue
Income Tax Act 1994
Resident Withholding Tax on Interest
Reissued Certificates of Exemption for the Period
01/04/02 to 31/03/03
| 10016894 | 10020638 | 10029627 | 10034337 | 10047374 |
| 10048028 | 10049067 | 10110599 | 10130972 | 10142474 |
| 10155193 | 10156106 | 10183383 | 10216567 | 10240697 |
| 10242681 | 10244927 | 10260531 | 10262852 | 10294568 |
| 10325536 | 10375061 | 10380030 | 10380359 | 10385938 |
| 10431298 | 10440041 | 10475023 | 10520541 | 10535794 |
| 10543207 | 10558018 | 10568900 | 10583969 | |
| 10604818 | 10655943 | 10669944 | 10680603 | 10681553 |
| 10688027 | 10688892 | 10691451 | 10700337 | 10707242 |
| 10730538 | 10732301 | 10748976 | 10759498 | 10764467 |
| 10774721 | 10787505 | 10806348 | 10807298 | 10809665 |
| 10863236 | 10888689 | 10902762 | 10915058 | 10923891 |
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2003, No 36
Gazette.govt.nz —
NZ Gazette 2003, No 36
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of Changed Medicines
(continued from previous page)
π₯ Health & Social Welfare3 April 2003
Medicines Act, Distribution consent, Changed medicines, Recormon
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of a New Related Product
π₯ Health & Social Welfare3 April 2003
Medicines Act, Distribution consent, New related product, Free & Lovely Dry/Sensitive Scalp
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Renewal of Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare3 April 2003
Medicines Act, Provisional consent, New medicine, Rescriptor
- G. R. Boyd, Chief Advisor, Safety and Regulation
π° Resident Withholding Tax on Interest
π° Finance & RevenueIncome Tax Act, Resident Withholding Tax, Interest, Certificates of Exemption